oligonucleotide drug

GSK’s $50m Acquisition Revolutionizes Oligonucleotide Drug Development

📢 GSK acquires Elsie Biotechnologies in a $50m deal to enhance its drug platform and develop treatments for difficult-to-treat diseases. 🧬👥🚀